All news from Anaesthesiology

Promising Results with Semaglutide in Phase II Weight Loss Trial

Obese patients experienced superior weight loss while taking semaglutide compared with liraglutide or placebo, in a phase 2 trial. "It is possible to achieve clinically worthwhile weight loss with medication," Dr. John P. H. Wilding reported. "However, we still need to see longer-term studies in people with a wider range of weight-related complications before semaglutide can be approved for weight management."